Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • Research Article
  • Cite Count Icon 1
  • 10.1159/000547674
Actein, a 9,19-Cyclobutane Triterpenoid from Cimicifuga spp., Ameliorates Atherosclerosis via ABCG1 and LXR Upregulation
  • Jul 29, 2025
  • Pharmacology
  • Siyun Xu + 6 more

  • Research Article
  • 10.1159/000547388
Combined Herbal Medicine (Achyranthes bidentata, Gastrodia elata, and Chaenomeles sinensis) Increases Anti-Inflammatory and Anti-Oxidative Effects in a Mouse Model of Amyotrophic Lateral Sclerosis
  • Jul 14, 2025
  • Pharmacology
  • Eun Jin Yang

  • Open Access Icon
  • Research Article
  • 10.1159/000547300
Amphotericin-A21 Induces Antineoplastic Effects through the Modulation of Apoptosis in Human Tumoral Cells
  • Jul 10, 2025
  • Pharmacology
  • Lourdes RodrĂ­guez-Fragoso + 5 more

  • Supplementary Content
  • 10.1159/000547223
Front & Back Matter
  • Jul 1, 2025
  • Pharmacology

  • Research Article
  • Cite Count Icon 1
  • 10.1159/000546838
SGLT2 Inhibitors May Increase Creatinine Clearance: Data Mining Utilizing the FDA Adverse Event Report System Database and Pharmacokinetic Study with Rats
  • Jun 25, 2025
  • Pharmacology
  • Yuichi Uwai + 1 more

  • Research Article
  • Cite Count Icon 2
  • 10.1159/000545929
Ginkgo biloba Extract Improved Paraquat-Induced Pulmonary Fibrosis via Inhibiting p38 MAPK Pathway
  • May 14, 2025
  • Pharmacology
  • Minxuan Peng + 4 more

  • Open Access Icon
  • Retracted
  • Addendum
  • 10.1159/000545109
Retraction Statement
  • Apr 29, 2025
  • Pharmacology
  • Z Zhu + 2 more

  • Open Access Icon
  • Supplementary Content
  • Cite Count Icon 2
  • 10.1159/000546061
The Effects and Mechanisms of Indole Derivatives in Improving Doxorubicin-Induced Cardiomyopathy
  • Apr 26, 2025
  • Pharmacology
  • Jing Sun + 6 more

Background: Doxorubicin is a first-line drug used in cancer chemotherapy, but its severe myocardial toxicity limits its widespread use. Indole derivatives, a large class of substances widely found in natural plants and metabolic products, exhibit a variety of biological effects. Summary: Previous studies have shown that indole compounds can protect against doxorubicin-induced myocardial damage through multiple mechanisms, including antioxidant activity, mitochondrial protection, anti-inflammatory effects, ferroptosis inhibition, apoptosis suppression, and endoplasmic reticulum stress attenuation. Understanding the pathogenesis of doxorubicin-induced cardiomyopathy and the molecular mechanisms by which indole compounds protect the myocardium is crucial for the development of novel drug molecules based on indole compounds in the future. Key Messages: Focusing on the molecular characteristics of indole derivatives, investigating their pharmacodynamics and safety, and developing safe and effective antagonistic molecules to counteract doxorubicin toxicity, holds great potential, and significance.

  • Open Access Icon
  • Retracted
  • Addendum
  • 10.1159/000544828
Retraction Statement
  • Apr 11, 2025
  • Pharmacology

  • Open Access Icon
  • Research Article
  • Cite Count Icon 12
  • 10.1159/000545659
Inhibition of Interleukin-8/C-X-C Chemokine Receptor 2 Signaling Axis Prevents Tumor Growth and Metastasis in Triple-Negative Breast Cancer Cells
  • Apr 4, 2025
  • Pharmacology
  • Yisun Jeong + 5 more